SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Targeting Sarbecovirus Family
Global phase 1/2 clinical trial initiated for GBP511, a vaccine targeting the Sarbecovirus Family
Next-generation vaccine leveraging SKYCovione’s recombinant pro...





